Ramucirumab with cisplatin and fluoropyrimidine does not increase survival in patients with metastatic gastric or gastro-oesophageal junctional adenocarcinoma. ecancer
ecancer,
By Monique Biryiana A phase III trial (RAINFALL) published in The Lancet Oncology reported that overall survival did not…